Cargando…

Prognostic Role Of Computed Tomography Textural Features In Early-Stage Non-Small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy

PURPOSE: The imaging features of patients with early-stage non-small cell lung cancer (NSCLC) receiving stereotactic body radiotherapy (SBRT) are crucial for the decision-making process to establish a treatment plan. The purpose of this study was to predict the clinical outcomes of SBRT from the tex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ran, Wang, Changbin, Cui, Kai, Chen, Yicong, Sun, Fenghao, Sun, Xiaorong, Xing, Ligang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883938/ https://www.ncbi.nlm.nih.gov/pubmed/31819630 http://dx.doi.org/10.2147/CMAR.S220587

Ejemplares similares

Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer
por: Li, Jing, et al.
Publicado: (2022)

Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis
por: Zhang, Ran, et al.
Publicado: (2022)

Characterization and clinical verification of immune-related genes in hepatocellular carcinoma to aid prognosis evaluation and immunotherapy
por: Qu, Jialin, et al.
Publicado: (2023)

A Propensity-Matched Analysis of Survival of Clinically Diagnosed Early-Stage Lung Cancer and Biopsy-Proven Early-Stage Non-Small Cell Lung Cancer Following Stereotactic Ablative Radiotherapy
por: Zhang, Ran, et al.
Publicado: (2021)

Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis
por: Li, Ming, et al.
Publicado: (2017)

Assessment and Prognostic Value of Immediate Changes in Post-Ablation Intratumor Density Heterogeneity of Pulmonary Tumors via Radiomics-Based Computed Tomography Features
por: Liu, Bo, et al.
Publicado: (2021)

The impact of pathologic staging of the hilar/mediastinal nodes on outcomes in patients with early-stage NSCLC receiving stereotactic body radiotherapy
por: Mullins, Brandon T., et al.
Publicado: (2021)

Five-year follow-up after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer: a multicenter study
por: Guo, Yanling, et al.
Publicado: (2023)

Functional status and spatial interaction of T cell subsets driven by specific tumor microenvironment correlate with recurrence of non-small cell lung cancer
por: Yang, Liying, et al.
Publicado: (2023)

Clinical utility of texture analysis of 18F-FDG PET/CT in patients with Stage I lung cancer treated with stereotactic body radiotherapy
por: Takeda, Kazuya, et al.
Publicado: (2017)

Stereotactic Body Radiotherapy for Early Stage Lung Cancer
por: Nagata, Yasushi
Publicado: (2013)

Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy
por: Kamogawa, Misaki, et al.
Publicado: (2022)

Cone‐beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients
por: Qin, Qingjin, et al.
Publicado: (2020)

Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy
por: Pyka, Thomas, et al.
Publicado: (2015)

Promising Outcomes in Acromegaly Patients Receiving CyberKnife Stereotactic Hypofractionated Radiotherapy
por: Meral, Rasim, et al.
Publicado: (2023)

Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2016)

Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases
por: Ingrosso, Gianluca, et al.
Publicado: (2012)

Predictive Value of Delta-Radiomics Texture Features in 0.35 Tesla Magnetic Resonance Setup Images Acquired During Stereotactic Ablative Radiotherapy of Pancreatic Cancer
por: Simpson, Garrett, et al.
Publicado: (2022)

A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with (68)Ga-labeled PD-L1 targeted nanobody
por: Qin, Songbing, et al.
Publicado: (2021)

Functional status and spatial architecture of tumor-infiltrating CD8+ T cells are associated with lymph node metastases in non-small cell lung cancer
por: Yang, Guanqun, et al.
Publicado: (2023)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

The clinical significance of computed tomography texture features of renal cell carcinoma in predicting pathological T1–3 staging
por: Tian, Li, et al.
Publicado: (2023)

Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease
por: Liu, Yuanjun, et al.
Publicado: (2020)

Stereotactic Radiotherapy for Oligometastasis
por: Otake, Sotaro, et al.
Publicado: (2019)

Radiobiology of stereotactic radiotherapy
por: Mangoni, Monica, et al.
Publicado: (2022)

Stereotactic radiotherapy for early stage non-small cell lung cancer
por: Ricardi, Umberto, et al.
Publicado: (2015)

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
por: Gkika, Eleni, et al.
Publicado: (2023)

PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy
por: Cho, Ick Joon, et al.
Publicado: (2022)

Neutrophil-lymphocyte ratio as a prognostic factor for stereotactic body radiotherapy treatment of metastatic liver tumors
por: Xie, Xuyun, et al.
Publicado: (2020)

Maximum diameter versus volumetric assessment for the response evaluation of vestibular schwannomas receiving stereotactic radiotherapy
por: Choi, Youngmin, et al.
Publicado: (2018)

Lack of an association between marital status and survival in patients receiving stereotactic body radiotherapy for early-stage non-small-cell lung cancer
por: Kishi, Noriko, et al.
Publicado: (2022)

Stage-Specific PET Radiomic Prediction Model for the Histological Subtype Classification of Non-Small-Cell Lung Cancer
por: Ji, Yanlei, et al.
Publicado: (2021)

Recurrence Features and Factors influencing Post-relapse Survival in Early-stage Endometrial Cancer after Adjuvant Radiotherapy
por: Ren, Kang, et al.
Publicado: (2022)

Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis
por: Shirata, Yuko, et al.
Publicado: (2012)

Establishing the Role of Stereotactic Ablative Body Radiotherapy in Early-Stage Breast Cancer
por: Barry, Aisling, et al.
Publicado: (2018)

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
por: Sun, Hui, et al.
Publicado: (2023)

Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy
por: Salvestrini, Viola, et al.
Publicado: (2022)

Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
por: Tran, Kevin T., et al.
Publicado: (2023)

Developments in Stereotactic Body Radiotherapy
por: Haridass, Anoop
Publicado: (2018)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q76rsnfbk8hh8s6hesbjir3b7s